CWM
ELDN icon

Congress Wealth Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Congress Wealth Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$27.1K Hold
10,000
– – ﹤0.01% 1175
2025
Q1 		$33.9K Buy
+10,000
New +$41.2K ﹤0.01% 1057

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Congress Wealth Management's ELDN Position: Q2 2025 in Review

Congress Wealth Management held its Eledon Pharmaceuticals (ELDN) position steady in Q2 2025 at 10,000 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

Congress Wealth Management first reported a position in ELDN in Q1 2025 and has held it in 2 quarters since. The position peaked at $33.9K in Q1 2025. 85 funds tracked by Wall St. Rank hold ELDN as of Q2 2025.

  • Congress Wealth Management held 10,000 shares of Eledon Pharmaceuticals worth $27.1K as of Q2 2025.
  • Congress Wealth Management left its Eledon Pharmaceuticals share count unchanged in Q2 2025.
  • Eledon Pharmaceuticals made up ﹤0.01% of Congress Wealth Management's portfolio in Q2 2025, its #1175 holding.
  • Congress Wealth Management first reported a position in Eledon Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • Congress Wealth Management's Eledon Pharmaceuticals position peaked at $33.9K in Q1 2025.
  • 85 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.